Selected article for: "acute ards respiratory distress syndrome and addition find"

Author: Pacha, Omar; Sallman, Mary Alice; Evans, Scott E.
Title: COVID-19: a case for inhibiting IL-17?
  • Cord-id: j63cpzj2
  • Document date: 2020_5_1
  • ID: j63cpzj2
    Snippet: IL-17 and IL-17 receptor inhibitors boast an impressive safety history and are widely available. Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a clinical trial of a drug in this class could be a logical addition to the effort to find effective therapies.
    Document: IL-17 and IL-17 receptor inhibitors boast an impressive safety history and are widely available. Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a clinical trial of a drug in this class could be a logical addition to the effort to find effective therapies.

    Search related documents:
    Co phrase search for related documents